StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 15/3087% below fair value
$4.66−0.18 (-3.72%)

Close on Nov 13, 2026Market cap $363.22MP/E –Yield –

CorMedix profit margin

Profit margin (net margin) is net income as a percentage of revenue.

CorMedix's profit margin for the twelve months ending Sep 30, 2026 was 15.5%. For fiscal 2025 it was 52.3%, against -41.2% the year before. The highest annual figure on record is 52.3% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202552.3%+93.6
FY2024Dec 31, 2024-41.2%+45368.7
FY2022Dec 31, 2022-45409.9%−30635.2
FY2021Dec 31, 2021-14774.7%−5567.0
FY2020Dec 31, 2020-9207.7%−3406.4
FY2019Dec 31, 2019-5801.3%+441.1
FY2018Dec 31, 2018-6242.4%+3781.1
FY2017Dec 31, 2017-10023.4%+973.0
FY2016Dec 31, 2016-10996.5%−2341.1
FY2015Dec 31, 2015-8655.4%+2150.9
FY2014Dec 31, 2014-10806.3%+445620.4
FY2013Dec 31, 2013-456426.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-27.0%−131.1
Q2 FY2026Jun 30, 202625.5%−24.4
Q1 FY2026Mar 31, 202630.3%−22.5
Q4 FY2025Dec 31, 202510.9%−32.2
Q3 FY2025Sep 30, 2025104.1%+128.3
Q2 FY2025Jun 30, 202549.9%+1805.4
Q1 FY2025Mar 31, 202552.8%+27690.5
Q4 FY2024Dec 31, 202443.1%+100581.8
Q3 FY2024Sep 30, 2024-24.2%+35758.2
Q2 FY2024Jun 30, 2024-1755.5%+90363.3
Q4 FY2022Dec 31, 2022-27637.7%−13823.2
Q3 FY2022Sep 30, 2022-100538.7%−78039.8
Q2 FY2022Jun 30, 2022-35782.4%+20778.9
Q1 FY2022Mar 31, 2022-92118.8%−83942.0
Q4 FY2021Dec 31, 2021-13814.5%−2889.2
Q3 FY2021Sep 30, 2021-22498.9%−15402.8
Q2 FY2021Jun 30, 2021-56561.3%−33558.0
Q1 FY2021Mar 31, 2021-8176.8%−672.1
Q4 FY2020Dec 31, 2020-10925.3%+10481.5
Q3 FY2020Sep 30, 2020-7096.1%+1748.0
Q2 FY2020Jun 30, 2020-23003.2%−21029.2
Q1 FY2020Mar 31, 2020-7504.7%−4347.7
Q4 FY2019Dec 31, 2019-21406.8%−29507.4
Q3 FY2019Sep 30, 2019-8844.0%−6096.2
Q2 FY2019Jun 30, 2019-1974.0%+111347.5
Q1 FY2019Mar 31, 2019-3157.1%+40725.4
Q4 FY2018Dec 31, 20188100.6%+19244.0
Q3 FY2018Sep 30, 2018-2747.8%+13554.0
Q2 FY2018Jun 30, 2018-113321.6%−109542.3
Q1 FY2018Mar 31, 2018-43882.5%−24678.6
Q4 FY2017Dec 31, 2017-11143.4%−5854.9
Q3 FY2017Sep 30, 2017-16301.8%–
Q2 FY2017Jun 30, 2017-3779.3%–
Q1 FY2017Mar 31, 2017-19203.9%–
Q4 FY2016Dec 31, 2016-5288.4%–

More CorMedix figures

See a number that looks wrong?